United States · FDA National Drug Code directory
venlafaxine hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-454_a0b75dbc-2382-70bc-7bd9-c6ef3ee4ed3e
- Product NDC
- 55111-454
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- venlafaxine hydrochloride
- Labeler
- Dr.Reddy's Laboratories Ltd.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110601
- Source listing expiry
- 20261231
Source-listed ingredients
- VENLAFAXINE HYDROCHLORIDE — 75 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (55111-454-01) · 55111-454-01
- 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (55111-454-05) · 55111-454-05
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (55111-454-30) · 55111-454-30
- 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (55111-454-60) · 55111-454-60
- 10 BLISTER PACK in 1 CARTON (55111-454-78) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (55111-454-79) · 55111-454-78
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (55111-454-90) · 55111-454-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →